Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines

Citation
N. Guiso et al., Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines, VACCINE, 17(19), 1999, pp. 2366-2376
Citations number
31
Categorie Soggetti
Veterinary Medicine/Animal Health",Immunology
Journal title
VACCINE
ISSN journal
0264410X → ACNP
Volume
17
Issue
19
Year of publication
1999
Pages
2366 - 2376
Database
ISI
SICI code
0264-410X(19990514)17:19<2366:IMMOBP>2.0.ZU;2-A
Abstract
Bicomponent, tricomponent and pertactin DTPa vaccines were tested in sublet hal aerosol, and lethal and sublethal intranasal murine Bordetella pertussi s respiratory challenge models. Pertactin and bicomponent vaccines induced protective immunity against lethality but with little or no bacterial clear ance. Intranasal challenge discriminated in a reproducible, statistically s ignificant manner between the efficacies of bicomponent and tricomponent DT Pa, in agreement with clinical trial data. This discrimination was not obse rved in the aerosol challenge. Pertactin had a synergistic effect with bico mponent DTPa. Intranasal challenge may be useful as part of the preclinical evaluation of new acellular pertussis formulations or DTPa-based combinati ons. (C) 1999 Published by Elsevier Science Ltd. All rights reserved.